YOLFTbeta
Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd

RGC · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

4.94USD-0.18 (-3.61%)

Price History

Full chart

Market Stats

Previous Close5.13
Open5.08
Day Range4.71 – 5.08
52-Week Range4.51 – 69.00
Volume118.85K
Market Cap3.33B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta1.17
50-Day Avg6.83
200-Day Avg17.15

About

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yat-Gai Au
  • Employees10
  • HeadquartersChinachem Leighton Plaza, Causeway Bay, Hong Kong, USA
  • Websitehttps://www.regencellbioscience.com

Leadership

  • Mr. Yat-Gai AuFounder, Chairman & CEO · b. 1973
  • Ms. Michelle ChanFinancial Controller, CFO & Principal Financial Officer
  • Mr. Wai Hong ChungCOO, Chief Strategy Officer & Director · b. 1978
  • Ms. Antonia AssangSenior Vice President of Project Management
  • Mr. Yat-Pui AuChief Business Officer · b. 1975

Financials

Income Statement

Currency: USD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue2.14B2.49B2.47B2.52B2.60B2.66B2.77B2.89B2.81B2.68B2.82B3.04B2.99B3.13B3.20B3.16B000000-0
Growth (%)-+16.31%-0.84%+1.94%+3.26%+2.42%+4.13%+4.44%-2.97%-4.49%+5.31%+7.57%-1.58%+4.59%+2.23%-1.07%-100.00%-------
Cost of Revenue84.00M92.00M94.00M96.00M104.00M103.00M106.00M1.16B101.00M96.00M101.00M111.00M111.00M1.21B1.23B123.00M-9.52K26.46K604.40K769.69K745.59K392.74K404.54K
Gross Profit2.06B2.40B2.37B2.42B2.49B2.56B2.67B1.74B2.71B2.59B2.72B2.93B2.88B1.92B1.97B3.04B--9.52K-26.46K-604.40K-769.69K-745.59K-392.74K-404.54K
Gross Margin96.07%96.30%96.19%96.18%96.00%96.13%96.17%60.02%96.40%96.42%96.42%96.35%96.29%61.39%61.63%96.11%--------
Operating Expense1.77B2.02B2.05B2.15B2.19B2.24B2.38B1.42B2.49B2.36B2.39B2.59B2.57B1.58B1.63B2.77B-802.86K1.35M7.01M5.50M3.99M3.38M11.32M
Operating Income283.00M379.00M321.00M269.00M308.00M322.00M284.00M313.40M215.80M221.30M334.20M339.80M306.40M339.00M344.20M271.70M-390.99K-812.37K-1.38M-7.62M-6.27M-4.74M-3.77M-11.72M
Operating Margin13.22%15.23%13.01%10.69%11.86%12.10%10.25%10.83%7.69%8.25%11.83%11.18%10.25%10.84%10.77%8.59%--------
EBITDA401.00M392.00M220.00M233.00M215.00M676.00M200.00M512.10M352.50M259.70M422.20M469.20M391.00M470.30M512.30M468.70M-390.99K-802.86K-1.35M-6.99M-5.29M-3.62M-3.19M-11.32M
EBITDA Margin18.74%15.75%8.91%9.26%8.28%25.40%7.22%17.70%12.55%9.68%14.95%15.44%13.08%15.04%16.02%14.82%--------
Net Income117.00M185.00M82.00M91.00M86.00M363.00M72.00M95.50M77.60M40.30M144.80M157.70M105.60M153.40M170.40M112.30M-390.99K-812.37K-1.35M-7.42M-5.87M-4.30M-3.58M-11.70M
Net Income Margin5.47%7.43%3.32%3.62%3.31%13.64%2.60%3.30%2.76%1.50%5.13%5.19%3.53%4.91%5.33%3.55%--------
R&D----------------228.22K386.23K438.32K2.51M1.58M1.07M948.29K1.30M
Interest Expense61.00M72.00M95.00M117.00M125.00M112.00M124.00M152.80M------0000023.21K----
Interest Expense % of Total Revenue2.85%2.89%3.85%4.65%4.81%4.21%4.47%5.28%------0.00%0.00%--------

Balance Sheet

Currency: USD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets2.31B2.47B2.54B2.53B2.47B2.63B2.60B2.64B2.49B2.34B2.21B2.70B2.54B2.63B2.65B2.84B243.31K514.02K340.13K18.02M12.62M8.44M5.76M14.73M
Total Liabilities1.04B1.67B2.47B2.50B2.49B2.75B2.84B2.88B2.98B2.91B2.91B3.42B3.43B3.51B3.48B3.70B2.08M3.16M4.34M938.03K632.32K219.51K895.31K1.38M
Total Equity1.27B798.00M71.00M31.00M-21.00M-119.00M-242.00M-246.90M-490.30M-570.90M-696.80M-713.40M-894.80M-877.60M-838.90M-855.80M-1.84M-2.65M-4.00M17.07M12.03M8.22M4.86M13.35M
Cash276.00M288.00M243.00M196.00M162.00M435.00M170.00M328.10M205.30M253.00M109.50M280.90M147.10M219.60M246.50M228.80M243.31K386.98K59.41K6.42M1.56M2.96M2.42M14.19M
Total Debt561.00M1.08B1.89B1.87B1.88B1.86B154.00M1.91B1.99B1.95B1.93B2.22B2.27B2.26B2.22B2.37B2.08M3.07M3.68M771.25K463.67K85.74K544.41K295.81K
Net Debt285.00M789.00M1.65B1.68B1.72B1.43B-16.00M1.58B1.79B1.69B1.82B1.94B2.12B2.04B1.98B2.14B1.84M2.68M3.62M-5.65M-1.10M-2.88M-1.87M-13.90M

Cash Flow

Currency: USD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow373.00M476.00M387.00M386.00M304.00M800.00M270.00M410.80M259.40M353.10M346.60M346.90M349.10M434.40M410.50M409.90M-390.99K-726.57K-767.31K-5.27M-4.96M-4.00M-3.11M-7.70M
Investing Cash Flow-----------------117.84K-117.84K-10.78M-10.78M58.98K5.24M2.69M2.50M
Financing Cash Flow-50.00M-281.00M--191.00M-186.00M-480.00M--142.40M-299.50M-204.30M-306.70M83.20M-332.40M-178.60M-160.00M-17.00M480.99K988.08K439.75K22.41M134.91K102.28K-16.95M
Capital Expenditure0000000108.80M98.40M87.20M89.20M112.10M156.80M185.70M214.90M250.40M117.84K117.84K1780.88K27.39K5.38K152.69K0
Free Cash Flow373.00M476.00M387.00M386.00M304.00M800.00M270.00M302.00M161.00M265.90M257.40M234.80M192.30M248.70M195.60M159.50M-390.99K-844.41K-767.31K-6.05M-4.99M-4.01M-3.27M-7.70M
Dividends Paid19.00M799.00M-175.00M179.00M485.00M-110.80M327.10M129.80M287.30M132.20M294.80M139.10M138.90M138.90M--------
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%73.52%62.07%75.30%74.26%67.69%55.08%57.25%47.65%38.91%100.00%116.22%100.00%114.83%100.55%100.13%104.90%100.00%
Dividend Paid to FCF5.09%167.86%-45.34%58.88%60.62%-36.69%203.17%48.82%111.62%56.30%153.30%55.93%71.01%87.08%--------

Earnings

Report DateSep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Apr 26, 2021Oct 29, 2021Jun 2, 2022Oct 31, 2022Oct 25, 2024Jun 30, 2025Nov 18, 2025Oct 30, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-
EPS Actual-0.01-0.01-0.03-0.03-0.02-0.02-0.05-33.38-0.11-0.29-0.300.000.000.00-
Surprise---------------
Timing----------After-hours--After-hours-

Key Statistics & Ratios

Market Cap3.33B
Enterprise Value3.31B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book249.25
EPS-0.02
Book Value0.027
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-11.64M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-128.53%
Return on Assets-71.54%
Shares Outstanding495.88M
Shares Float55.56M
Beta1.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.28%
Insiders
88.55%
Retail / Other
11.17%

Top Institutional Holders

  • Geode Capital Management, LLC
    422.01K0.09%
  • Alyeska Investment Group, L.P.
    416.26K0.08%
  • Legal & General Group PLC
    128.00K0.03%
  • Jane Street Group LLC
    98.35K0.02%
  • XTX Topco Ltd
    60.06K0.01%
  • Amundi
    47.16K0.01%
  • UBS Group AG
    43.21K0.01%
  • Quadrature Capital Limited
    41.75K0.01%
  • Susquehanna International Group, LLP
    23.13K0.00%
  • Squarepoint Ops LLC
    22.04K0.00%
  • Fox Run Management LLC
    20.69K0.00%
  • CIBC Global Asset Management Inc
    15.29K0.00%
  • Bank of America Corp
    14.99K0.00%
  • Two Sigma Investments LLC
    14.41K0.00%
  • Vident Advisory, LLC
    11.20K0.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    301.86K0.06%
  • Fidelity Nasdaq Composite ETF
    122.52K0.02%
  • CIBC US Broad Market Index
    15.29K0.00%
  • JHVIT Total Stock Market Index I
    7.65K0.00%
  • undrly FID DCL&G LwCarbTrnstnGlbEqUnHOFC
    6.76K0.00%

Stock Splits

  • Jun 16, 202538:1